ExonHit Therapeutics Inc.

47 articles about ExonHit Therapeutics Inc.

• ExonHit Therapeutics Inc. Receives € 1.93 Million from OSEO Within the Personalized Medicine TEDAC Project in Cancer

  6/5/2012

• ExonHit Therapeutics Inc. is Beneficiary of a Grant from the European Union Within the Responsify Consortium

  3/5/2012

• ExonHit Therapeutics Inc.: AclarusDx®: Launch of Observational Study in France

  12/12/2011

• ExonHit Therapeutics Inc. Extends Strategic Collaboration with Allergan Inc.

  11/2/2011

• Approval of US Pilot Clinical Trial to Evaluate AclarusDx(™), the ExonHit Therapeutics Inc. Investigational Test for Alzheimer’s Disease Diagnosis

  10/26/2011

• ExonHit Therapeutics Inc. and Beijing Genomics Institute (BGI) Announce Successful Completion of a Promising Next-Generation Sequencing Project

  7/25/2011

• ExonHit Therapeutics Inc. Announces Successful Completion of the Second Phase of EHT Dx14 Clinical Validation

  7/19/2011

• ExonHit Therapeutics Inc. Reports Key Progress in the Introduction of AclarusDx(TM) in the French IVD Market

  6/29/2011

• ExonHit Therapeutics Inc.'s Extraordinary Shareholders’ Meeting

  5/18/2011

• ExonHit Therapeutics Inc. Announces Publication of EHT 0202 Phase IIa Results in Current Alzheimer Research

  4/5/2011

• ExonHit Therapeutics Inc. Reports 2010 Results

  3/15/2011

• ExonHit Therapeutics Inc. Announces CE Marking of AclarusDx

  3/15/2011

• ExonHit Therapeutics Inc. Awarded Two Discovery Grants by the US Federal Government

  12/20/2010

• ExonHit Therapeutics Inc. Presents Promising Data on Genomic Biomarkers in Alzheimer's Disease Clinical Trials

  11/9/2010

• ExonHit Therapeutics Inc. Backs out of $22.5M Agreement to Acquire RedPath Integrated Pathology

  10/26/2010

• ExonHit Therapeutics Inc. Announces Termination of Agreement to Acquire RedPath Integrated Pathology, Inc.

  10/25/2010

• ExonHit Therapeutics Inc. - Strong Growth of Half-Year 2010 Results

  9/16/2010

• ExonHit Therapeutics Inc.'s Extraordinary Shareholders' Meeting on Second Notice

  7/9/2010

• ExonHit Therapeutics Inc. Updates its Shareholders Regarding the Extraordinary Shareholders’ Meeting About RedPath Integrated Pathology, Inc. Acquisition

  6/23/2010

• ExonHit Therapeutics Inc. Updates its Shareholders on the Acquisition of RedPath Integrated Pathology, Inc.

  6/18/2010